321 related articles for article (PubMed ID: 10549683)
41. Comparison of continuous versus intermittent administration of zolpidem in chronic insomniacs: a double-blind, randomized pilot study.
Cluydts R; Peeters K; de Bouyalsky I; Lavoisy J
J Int Med Res; 1998; 26(1):13-24. PubMed ID: 9513073
[TBL] [Abstract][Full Text] [Related]
42. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
Hajak G; Hedner J; Eglin M; Loft H; Stórustovu SI; Lütolf S; Lundahl J;
Sleep Med; 2009 Aug; 10(7):705-12. PubMed ID: 19346160
[TBL] [Abstract][Full Text] [Related]
43. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.
Feighner JP; Overø K
J Clin Psychiatry; 1999 Dec; 60(12):824-30. PubMed ID: 10665628
[TBL] [Abstract][Full Text] [Related]
44. Zolpidem for insomnia.
Greenblatt DJ; Roth T
Expert Opin Pharmacother; 2012 Apr; 13(6):879-93. PubMed ID: 22424586
[TBL] [Abstract][Full Text] [Related]
45. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
Roger M; Attali P; Coquelin JP
Clin Ther; 1993; 15(1):127-36. PubMed ID: 8458042
[TBL] [Abstract][Full Text] [Related]
46. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.
Krystal AD; Walsh JK; Laska E; Caron J; Amato DA; Wessel TC; Roth T
Sleep; 2003 Nov; 26(7):793-9. PubMed ID: 14655910
[TBL] [Abstract][Full Text] [Related]
47. Reducing Suicidal Ideation Through Insomnia Treatment (REST-IT): A Randomized Clinical Trial.
McCall WV; Benca RM; Rosenquist PB; Youssef NA; McCloud L; Newman JC; Case D; Rumble ME; Szabo ST; Phillips M; Krystal AD
Am J Psychiatry; 2019 Nov; 176(11):957-965. PubMed ID: 31537089
[TBL] [Abstract][Full Text] [Related]
48. Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age.
Blumer JL; Findling RL; Shih WJ; Soubrane C; Reed MD
Pediatrics; 2009 May; 123(5):e770-6. PubMed ID: 19403468
[TBL] [Abstract][Full Text] [Related]
49. A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers.
Paterson LM; Wilson SJ; Nutt DJ; Hutson PH; Ivarsson M
Psychopharmacology (Berl); 2007 May; 191(4):943-50. PubMed ID: 17225163
[TBL] [Abstract][Full Text] [Related]
50. A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects.
Voderholzer U; Riemann D; Hornyak M; Backhaus J; Feige B; Berger M; Hohagen F
Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):117-23. PubMed ID: 11697572
[TBL] [Abstract][Full Text] [Related]
51. Effects of zolpidem and flunitrazepam on nocturnal sleep of women subjectively complaining of insomnia.
Declerck AC; Ruwe F; O'Hanlon JF; Vermeeren A; Wauquier A
Psychopharmacology (Berl); 1992; 106(4):497-501. PubMed ID: 1579623
[TBL] [Abstract][Full Text] [Related]
52. Conventional and power spectrum analysis of the effects of zolpidem on sleep EEG in patients with chronic primary insomnia.
Monti JM; Alvariño F; Monti D
Sleep; 2000 Dec; 23(8):1075-84. PubMed ID: 11145322
[TBL] [Abstract][Full Text] [Related]
53. Zolpidem extended-release.
Moen MD; Plosker GL
CNS Drugs; 2006; 20(5):419-26; discussion 427-8. PubMed ID: 16696581
[TBL] [Abstract][Full Text] [Related]
54. Antidepressants for insomnia in adults.
Everitt H; Baldwin DS; Stuart B; Lipinska G; Mayers A; Malizia AL; Manson CC; Wilson S
Cochrane Database Syst Rev; 2018 May; 5(5):CD010753. PubMed ID: 29761479
[TBL] [Abstract][Full Text] [Related]
55. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
Miner CM; Brown EB; Gonzales JS; Munir R
J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
[TBL] [Abstract][Full Text] [Related]
56. Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal.
Vandrey R; Smith MT; McCann UD; Budney AJ; Curran EM
Drug Alcohol Depend; 2011 Aug; 117(1):38-44. PubMed ID: 21296508
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia.
Krystal AD; Lankford A; Durrence HH; Ludington E; Jochelson P; Rogowski R; Roth T
Sleep; 2011 Oct; 34(10):1433-42. PubMed ID: 21966075
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.
Silverstone PH; Salinas E
J Clin Psychiatry; 2001 Jul; 62(7):523-9. PubMed ID: 11488362
[TBL] [Abstract][Full Text] [Related]
59. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.
Ancoli-Israel S; Krystal AD; McCall WV; Schaefer K; Wilson A; Claus R; Rubens R; Roth T
Sleep; 2010 Feb; 33(2):225-34. PubMed ID: 20175406
[TBL] [Abstract][Full Text] [Related]
60. A double-blind comparative study of zolpidem versus zopiclone in the treatment of chronic primary insomnia.
Tsutsui S;
J Int Med Res; 2001; 29(3):163-77. PubMed ID: 11471853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
